Formulir Kontak

Nama

Email *

Pesan *

Cari Blog Ini

Taylor Wessing Advises Cumulus Oncology On Its Exclusive Gpr68 Licence And Development Collaboration With Leadxpro

Taylor Wessing Advises Cumulus Oncology on GPR68 Collaboration

Exclusive Licence and Development Collaboration with leadXpro

International law firm Taylor Wessing has successfully advised Cumulus Oncology, a clinical-stage oncology company developing radiopharmaceuticals targeting cancer, on its exclusive worldwide licence and development collaboration agreement with leadXpro, a radiopharmaceutical company.

Under the terms of the agreement, leadXpro has granted Cumulus Oncology an exclusive worldwide licence to develop and commercialise leadXpro's novel prostate-specific membrane antigen (PSMA)-targeted radioligand, [177Lu]Lu-PSMA-617, for use in the treatment of prostate cancer.

Transaction Highlights

  • Taylor Wessing advised Cumulus Oncology on all aspects of the transaction, including negotiation of the licence agreement, regulatory and compliance matters, and intellectual property.
  • The transaction closed on 31 March 2023.
  • The Taylor Wessing team was led by Life Sciences & Healthcare partner Simon Burns, with support from senior associate Alice Collett and associate Katie Ayres.

About Cumulus Oncology

Cumulus Oncology is a clinical-stage oncology company developing a pipeline of radiopharmaceuticals targeting cancer. The company's lead product candidate, [177Lu]Lu-PSMA-617, is a PSMA-targeted radioligand that has shown promising results in clinical trials for the treatment of prostate cancer.

About leadXpro

leadXpro is a radiopharmaceutical company focused on the development of innovative radioligands for the treatment of cancer. The company's lead product candidate, [177Lu]Lu-PSMA-617, is a PSMA-targeted radioligand that has shown promising results in clinical trials for the treatment of prostate cancer.

Taylor Wessing is a leading international law firm with a focus on the technology, media, telecommunications, and life sciences sectors. The firm has a team of experienced life sciences lawyers who advise clients on a wide range of matters, including licensing, regulatory compliance, and intellectual property.


Komentar